25,021 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Jupiter Topco LLC

Jupiter Topco LLC purchased a new stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 25,021 shares of the medical equipment provider's stock, valued at approximately $2,156,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. OMERS ADMINISTRATION Corp bought a new position in Zimmer Biomet during the second quarter worth about $922,000. Hsbc Holdings PLC bought a new stake in Zimmer Biomet in the 2nd quarter valued at about $35,417,000. PNC Financial Services Group Inc. boosted its holdings in Zimmer Biomet by 9.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 161,195 shares of the medical equipment provider's stock valued at $14,495,000 after purchasing an additional 13,883 shares during the period. Morningstar Investment Management LLC grew its position in shares of Zimmer Biomet by 235.4% during the 4th quarter. Morningstar Investment Management LLC now owns 57,865 shares of the medical equipment provider's stock worth $5,204,000 after purchasing an additional 40,610 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in shares of Zimmer Biomet by 257.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 34,370 shares of the medical equipment provider's stock worth $3,091,000 after purchasing an additional 24,748 shares during the period. 88.89% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on ZBH shares. UBS Group reiterated a "buy" rating and issued a $120.00 price target on shares of Zimmer Biomet in a research report on Thursday, August 6th. Needham & Company LLC restated a "hold" rating on shares of Zimmer Biomet in a research note on Wednesday, August 5th. Zacks Research raised Zimmer Biomet from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 25th. Citigroup cut their target price on Zimmer Biomet from $95.00 to $93.00 and set a "neutral" rating for the company in a research report on Thursday, May 28th. Finally, Sanford C. Bernstein increased their target price on Zimmer Biomet from $91.00 to $93.00 and gave the stock a "market perform" rating in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, fourteen have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, Zimmer Biomet has a consensus rating of "Hold" and an average target price of $104.42.

Zimmer Biomet Stock Performance

Shares of Zimmer Biomet stock opened at $98.88 on Friday. The company has a current ratio of 1.69, a quick ratio of 0.94 and a debt-to-equity ratio of 0.50. The company has a market cap of $18.86 billion, a PE ratio of 24.06, a price-to-earnings-growth ratio of 1.88 and a beta of 0.47. The company has a 50 day moving average of $94.72 and a 200-day moving average of $91.60. Zimmer Biomet Holdings, Inc. has a 1-year low of $79.12 and a 1-year high of $106.88.

Zimmer Biomet (NYSE:ZBH - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The medical equipment provider reported $2.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.01 by $0.06. Zimmer Biomet had a net margin of 9.48% and a return on equity of 13.12%. The business had revenue of $2.18 billion for the quarter, compared to analysts' expectations of $2.13 billion. During the same period last year, the firm posted $2.07 earnings per share. The firm's quarterly revenue was up 4.8% compared to the same quarter last year. Zimmer Biomet has set its FY 2026 guidance at 8.470-8.590 EPS. As a group, equities research analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.54 earnings per share for the current fiscal year.

Zimmer Biomet Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.24 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $0.96 annualized dividend and a dividend yield of 1.0%. Zimmer Biomet's dividend payout ratio (DPR) is presently 23.36%.

Zimmer Biomet Profile

Zimmer Biomet NYSE: ZBH is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company's product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source